INCENP
Inner centromere protein
Also known as: FLJ31633, INCE_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NQS7
- Gene
- INCENP
- Ensembl
- ENSG00000149503
- Chromosome
- 11
- Canonical length
- 918 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies,Kinetochore,Midbody
- Quaternary structure
- Homodimer
OverviewNCBI Gene
In mammalian cells, 2 broad groups of centromere-interacting proteins have been described: constitutively binding centromere proteins and 'passenger,' or transiently interacting, proteins (reviewed by Choo, 1997). The constitutive proteins include CENPA (centromere protein A; MIM 117139), CENPB (MIM 117140), CENPC1 (MIM 117141), and CENPD (MIM 117142). The term 'passenger proteins' encompasses a broad collection of proteins that localize to the centromere during specific stages of the cell cycle (Earnshaw and Mackay, 1994 [PubMed 8088460]). These include CENPE (MIM 117143); MCAK (MIM 604538); KID (MIM 603213); cytoplasmic dynein (e.g., MIM 600112); CliPs (e.g., MIM 179838); and CENPF/mitosin (MIM 600236). The inner centromere proteins (INCENPs) (Earnshaw and Cooke, 1991 [PubMed 1860899]), the initial members of the passenger protein group, display a broad localization along chromosomes in the early stages of mitosis but gradually become concentrated at centromeres as the cell cycle progresses into mid-metaphase. During telophase, the proteins are located within the midbody in the intercellular bridge, where they are discarded after cytokinesis (Cutts et al., 1999 [PubMed 10369859]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
918 residues, UniProt reviewed canonical sequence.
>Q9NQS7|INCENP
1 MGTTAPGPIH LLELCDQKLM EFLCNMDNKD LVWLEEIQEE AERMFTREFS KEPELMPKTP
61 SQKNRRKKRR ISYVQDENRD PIRRRLSRRK SRSSQLSSRR LRSKDSVEKL ATVVGENGSV
121 LRRVTRAAAA AAAATMALAA PSSPTPESPT MLTKKPEDNH TQCQLVPVVE IGISERQNAE
181 QHVTQLMSTE PLPRTLSPTP ASATAPTSQG IPTSDEESTP KKSKARILES ITVSSLMATP
241 QDPKGQGVGT GRSASKLRIA QVSPGPRDSP AFPDSPWRER VLAPILPDNF STPTGSRTDS
301 QSVRHSPIAP SSPSPQVLAQ KYSLVAKQES VVRRASRRLA KKTAEEPAAS GRIICHSYLE
361 RLLNVEVPQK VGSEQKEPPE EAEPVAAAEP EVPENNGNNS WPHNDTEIAN STPNPKPAAS
421 SPETPSAGQQ EAKTDQADGP REPPQSARRK RSYKQAVSEL DEEQHLEDEE LQPPRSKTPS
481 SPCPASKVVR PLRTFLHTVQ RNQMLMTPTS APRSVMKSFI KRNTPLRMDP KCSFVEKERQ
541 RLENLRRKEE AEQLRRQKVE EDKRRRLEEV KLKREERLRK VLQARERVEQ MKEEKKKQIE
601 QKFAQIDEKT EKAKEERLAE EKAKKKAAAK KMEEVEARRK QEEEARRLRW LQQEEEERRH
661 QELLQKKKEE EQERLRKAAE AKRLAEQREQ ERREQERREQ ERREQERREQ ERREQERQLA
721 EQERRREQER LQAERELQER EKALRLQKEQ LQRELEEKKK KEEQQRLAER QLQEEQEKKA
781 KEAAGASKAL NVTVDVQSPA CTSYQMTPQG HRAPPKINPD NYGMDLNSDD STDDEAHPRK
841 PIPTWARGTP LSQAIIHQYY HPPNLLELFG TILPLDLEDI FKKSKPRYHK RTSSAVWNSP
901 PLQGARVPSS LAYSLKKHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against INCENP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.64
- Highest tissue expression
- 20 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 20 nTPM
- thymus: 17 nTPM
- esophagus: 13 nTPM
- lymph node: 11 nTPM
- cerebellum: 9.9 nTPM
- tonsil: 7.7 nTPM
Single-cell type
- monocyte progenitors: 80 nCPM
- erythrocyte progenitors: 41 nCPM
- esophageal apical cells: 41 nCPM
- megakaryocyte progenitors: 39 nCPM
- neutrophil progenitors: 31 nCPM
- esophageal suprabasal cells: 18 nCPM
Immune cell
- basophil: 1.2 nTPM
- NK-cell: 1.1 nTPM
- classical monocyte: 0.1 nTPM
- naive CD8 T-cell: 0.1 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- cerebellum: 25 nTPM
- cerebral cortex: 19 nTPM
- amygdala: 18 nTPM
- hippocampal formation: 18 nTPM
- pons: 16 nTPM
- white matter: 15 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about INCENP.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 294 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.34
- gnomAD pLI
- 0.89
- gnomAD missense Z
- 0.77
- DepMap mean gene effect
- -1.1
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- chromosome segregation
- meiotic spindle midzone assembly
- metaphase chromosome alignment
- mitotic cell cycle
- mitotic cytokinesis
- mitotic spindle assembly
- mitotic spindle midzone assembly
- positive regulation of attachment of mitotic spindle microtubules to kinetochore
- positive regulation of mitotic cell cycle spindle assembly checkpoint
- positive regulation of mitotic cytokinesis
- positive regulation of mitotic sister chromatid separation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Inner centromere protein, ARK-binding domain
- Chromosome passenger complex (CPC) protein INCENP N-terminal
- Inner centromere protein, ARK binding region
- Chromosome passenger complex (CPC) protein INCENP N terminal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of INCENP in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads INCENP as an antibody target. Whether an autoantibody or antibody against INCENP could matter depends on whether native INCENP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
INCENP is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label INCENP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...